Site icon fundsforNGOs

RFAs: Advancing Regulatory Science for Patient-Centred Health Technologies

Community Strengthening Grants - Healthy Active Living Stream (Australia)

Deadline: 16-Apr-26

The European Commission is offering funding under Horizon Europe to advance regulatory science for patient-centred health technologies. With a total budget of €19.6 million and grants between €4 million and €6 million, the programme supports improved evaluation methods and faster adoption of safe, effective innovations.
The focus is on evidence-based regulation, digital health technologies, and lifecycle assessment to enhance healthcare outcomes across the EU.

This programme supports research and innovation in regulatory science, aiming to improve how health technologies are evaluated, approved, and adopted.

It focuses on strengthening the evidence base and methodologies used by regulators to ensure that innovative healthcare solutions are:

Key Programme Details

Funding Information

Programme Objectives

Core Focus Areas

1. Regulatory Science Innovation

2. Evidence Generation and Evaluation

3. Lifecycle Approach to Health Technologies

4. Digital and Biomedical Innovation

5. Policy and Regulatory Impact

What Type of Projects Are Funded?

The programme funds pre-competitive research and innovation, including:

Key Project Requirements

Projects must:

Who Is Eligible?

Eligible Participants

H3: Participation Requirements

H3: Consortium Expectations

Why This Programme Matters

H3: Improving Healthcare Innovation Uptake

H3: Strengthening Patient Safety

H3: Supporting Digital Transformation

How to Apply (Step-by-Step Guide)

Step 1: Identify the Call

Step 2: Register Your Organisation

Step 3: Build a Consortium

Step 4: Develop the Proposal

Step 5: Plan for Implementation

Step 6: Submit Application

Common Mistakes to Avoid

Tips for a Strong Application

Frequently Asked Questions (FAQ)

1. Who can apply for this funding?

Any legal entity worldwide, including universities, companies, NGOs, and international organisations.

2. What is the funding range?

Projects receive between €4 million and €6 million.

3. What is regulatory science?

It is the science of developing tools, standards, and approaches to evaluate the safety, effectiveness, and quality of health technologies.

4. Is a consortium required?

Collaboration is strongly encouraged, especially across sectors and disciplines.

5. What technologies are supported?

AI, digital health tools, predictive models, and biomedical innovations.

6. What is meant by lifecycle approach?

It refers to evaluating technologies from development through post-market monitoring.

7. What outcomes are expected?

Improved regulatory frameworks, faster adoption of innovations, and better patient outcomes.

Conclusion

The European Commission Regulatory Science Grants offer a strategic opportunity to modernise how healthcare innovations are evaluated and adopted.

By strengthening evidence-based methodologies and integrating advanced technologies, this programme supports safer, faster, and more effective healthcare innovation across Europe.

For more information, visit European Commission.

Exit mobile version